Clinical Trial Update: Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing whether CDP-Choline (citicoline) improves gating and cognitive deficits in individuals experiencing their first episode of schi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia First-episode

Drugs mentioned

• CDP-choline (citicoline)

Snippet

Sponsor: University of Ottawa | Conditions: First Episode Schizophrenia | Phase 2 | Status: UNKNOWN